Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 574-578

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Avanzas, Pablo ^c   Laynez Cerdeña, Ignacio ^a   Kaski, Juan Carlos ^d  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Inflammation; Left ventricular remodeling; Neopterin; Percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NEOPTERIN;

ADULT; ARTICLE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NEOPTERIN; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE; VENTRICULAR REMODELING;

EID: 77955270286     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.017     Document Type: Article

References (21)

1. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Circulation 1990, 81:1161-1172.
2. Garcia-Alvarez A., Sitges M., Delgado V., et al. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol 2009, 104:878-882.
3. Rudzite V., Skards J.I., Fuchs D., Reibnegger G., Wachter H. Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. Immunol Lett 1992, 32:125-129.
4. Vonhof S., Brost B., Stille-Siegener M., et al. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol 1998, 63:237-244.
5. Estévez-Loureiro R., Recio-Mayoral A., Sieira-Rodríguez-Moret J.A., Trallero-Araguás E., Kaski J.C. Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. Atherosclerosis 2009, 10.1016/j.atherosclerosis.2009:04.032.
6. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M. Usefulness of neopterin levels and left ventricular function for risk assessment in survivors of acute myocardial infarction. Int J Cardiol 2006, 111:318-320.
7. Maekawa Y., Anzai T., Yoshikawa T., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002, 39:241-246.
8. Van de Werf F., Ardissino D., Betriu A., Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology, et al. Management of acute myocardial infarction in patients with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003, 24:28-66.
9. Silber S., Albertsson P., Avilés F.F., et al. Task force for percutaneous coronary interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. Eur Heart J 2005, 26:804-847.
10. Garcia-Gonzalez M.J., Dominguez-Rodriguez A., Abreu-Gonzalez P. Light-dark variations in neopterin serum levels in patients with ST-segment elevation acute coronary syndrome undergoing primary angioplasty. Rev Esp Cardiol 2008, 61:1280-1286.
11. Dominguez-Rodriguez A., Abreu-Gonzalez P., Kaski J.C. Inflammatory systemic biomarkers in setting acute coronary syndromes - effects of the diurnal variation. Curr Drug Targets 2009, 10:1001-1008.
12. Kan G., Visser C.A., Lie K.I., Durrer D. Early two-dimensional echocardiographic measurement of left ventricular ejection fraction in acute myocardial infarction. Eur Heart J 1984, 5:210-217.
13. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., Quinones M.A. Doppler tissue imaging: a non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997, 30:1527-1533.
14. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
15. Savoye C., Equine O., Tricot O., et al. Left ventricular remodeling alter anterior wall acute myocardial infarction in modern clinical practice (from the Remodelage Ventriculaire [REVE] study group). Am J Cardiol 2006, 98:1144-1149.
16. Gaudron P., Eilles C., Kugler I., Ertl G. Progressive left ventricular dysfunction and remodelling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993, 87:755-763.
17. Bolognese L., Neskovic A.N., Parodi G., et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002, 106:2351-2357.
18. Hirayama A., Kusuoka H., Yamamoto H., et al. Usefulness of plasma brain natriuretic peptide concentration for predicting subsequent left ventricular remodeling after coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol 2006, 98:453-457.
19. Margreiter J., Schlager A., Balogh A., et al. Exogenous neopterin causes cardiac contractile dysfunction in the isolated perfused rat heart. J Mol Cell Cardiol 2000, 32:1265-1274.
20. Hirayama A., Kusuoka H., Yamamoto H., et al. Serial changes in plasma brain natriuretic peptide concentration at the infarct and non-infarct sites in patients with left ventricular remodelling after myocardial infarction. Heart 2005, 91:1573-1577.
21. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial: phase 1 findings. N Engl J Med 1985, 312:932-936.